ROCKWELL MEDICAL, INC. 10-Q

Item 5. Other Information. None . Item 6. Exhibits The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth on the Exhibit Index, which Exhibit Index is incorporated herein by reference. EXHIBIT INDEX Exhibit No. Description 10.1* Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan. 10.2* Performance Based Restricted Stock Unit Award Agreement. 31.1* Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 31.2* Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 32.1** Certification pursuant to 18 U.S.C. Section 1350 and Rule 13a-14(b) of the Securities Exchange Act of 1934 32.2** Certification pursuant to 18 U.S.C. Section 1350 and Rule 13a-14(b) of the Securities Exchange Act of 1934 101.INS* XBRL Instance Document 101.SCH* XBRL Taxonomy Extension Schema 101.CAL* XBRL Taxonomy Extension Calculation Linkbase 101.DEF* XBRL Taxonomy Extension Definition Database 101.LAB* XBRL Taxonomy Extension Label Linkbase 101.PRE* XBRL Taxonomy Extension Presentation Linkbase 104* The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, formatted in Inline XBRL (included as Exhibit 101) * Filed herewith ** Furnished herewith and not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act 22 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ROCKWELL MEDICAL, INC. (Registrant) Date: August 14, 2025 /s/ Mark Strobeck Mark Strobeck, Ph.D. President, Chief Executive Officer and Director (Principal Executive Officer) 23